Inthrani R Indran
Overview
Explore the profile of Inthrani R Indran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Riepsamen A, Donoghoe M, Indran I, Hechtman L, Robertson D, Gilchrist R, et al.
Clin Endocrinol (Oxf)
. 2022 Nov;
98(4):567-577.
PMID: 36372988
Objective: Growth differentiation factor-9 (GDF9) and bone morphogenetic protein-15 (BMP15) are critical paracrine regulators of female fertility and are predominantly expressed by oocytes. However, it is unknown if serum concentrations...
2.
Neubronner S, Indran I, Chan Y, Thu A, Yong E
BMC Womens Health
. 2021 Apr;
21(1):135.
PMID: 33794861
Background: A diagnosis of Polycystic Ovary Syndrome (PCOS) and its related phenotypic features including increased hair growth can affect a woman's social and emotional well-being. We aim to determine firstly,...
3.
Lim A, Indran I, Kramer M, Yong E
Endocrinol Diabetes Metab
. 2019 Jul;
2(3):e00047.
PMID: 31294078
Objective: Firstly, to investigate whether polycystic ovary syndrome (PCOS) shows a continuum of severity with increasing number of phenotypic features comprising the Rotterdam criteria for PCOS and secondly, to explore...
4.
Indran I, Huang Z, Khin L, Chan J, Viardot-Foucault V, Yong E
Clin Endocrinol (Oxf)
. 2018 Jun;
89(2):202-211.
PMID: 29851127
Objectives: Although the Rotterdam 2003 polycystic ovarian syndrome (PCOS) diagnostic criteria is widely used, the need to consider multiple variables makes it unwieldy in clinical practice. We propose a simplified...
5.
Sun F, Indran I, Zhang Z, Tan M, Li Y, Lim Z, et al.
Carcinogenesis
. 2015 Apr;
36(7):757-68.
PMID: 25908644
Persistent androgen receptor (AR) signaling is the key driving force behind progression and development of castration-resistant prostate cancer (CRPC). In many patients, AR COOH-terminal truncated splice variants (ARvs) play a...
6.
Indran I, Tufo G, Pervaiz S, Brenner C
Biochim Biophys Acta
. 2011 Apr;
1807(6):735-45.
PMID: 21453675
Defective or inefficient apoptosis is an acquired hallmark of cancer cells. Thus, a thorough understanding of apoptotic signaling pathways and insights into apoptosis resistance mechanisms are imperative to unravel novel...
7.
Indran I, Hande M, Pervaiz S
Cancer Res
. 2010 Nov;
71(1):266-76.
PMID: 21071633
The human telomerase reverse transcriptase (hTERT) is the catalytic subunit of the telomerase holoenzyme. Evidence is accumulating to link hTERT to activities other than telomere maintenance and immortalization. Here, we...